Complications after post placental insertion of Cu T 380 A in women undergoing caesarean delivery

Authors

  • Dineshwar Singh Department of Obstetrics and Gynecology, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India
  • Sita Thakur Department of Obstetrics and Gynecology, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20203327

Keywords:

Elective/emergency admission, Family planning, Intra uterine contraceptive device, Postpartum contraception, Cu-T 380 A

Abstract

Background: India is the second most populated country in the world after China with more than a billion people and has highest number of maternal deaths in the world. The aim of the study was to find out the complications after insertion of post placental Cu T 380 A in women undergoing caesarean delivery.

Methods: A prospective observational study was carried out in the department of obstetrics and gynecology, Dr RPGMC Kangra (Rural Medical College) after taking approval of Protocol Review and Institutional Ethics Committee of the Institution. A total of 104 women delivering by caesarean section and wanting post-placental intra-caesarean Cu T 380 A insertion and who were meeting WHO standard medical criteria for PPIUCD insertion and were willing to comply with the study protocol was recruited for the study.

Results: There were no major complications and only minor side effects like pain and fever were observed in 6.25 and 6.90 and 9.37 and 11.11% of women who were admitted electively and in emergency, respectively during follow-up visit up to 6 months. String became visible in 72.12% of women at the 6 weeks follow-up visit and their visibilities increased with time and at 6 months follow-up in 90.81% of the cases. Continuation rate was 100% at 6 weeks post-partum follow-up. After that spontaneous expulsion occurred in 4 cases (3.84%) and another 4 women (3.84%) requested removal for various reasons leading to continuation rate of 92.30% at six months post-partum follow-up. There was no case of pregnancy with Cu T in situ with no failure at the end of study at six months post-partum.

Conclusions: Post placental insertion of Cu T 380 A in women undergoing caesarean section was safe and effective method of postpartum family planning, the complaints and complications initially increased but decreased at 6 months follow-up.

References

Singh S, Malik R, Ahalawat R, Taneja BK. Evaluation of efficacy, expulsion and safety of post-placental and intra-caesarean insertion of intrauterine contraceptive devices. Int J Reprod Contracept Obstet Gynecol. 2015;4(6):2005-9.

IUCD reference manual for medical officers and nursing personnel. Family Planning Division, Ministry of Health and Family Welfare, Government of India; 2013:1.

Vansjaliya H, Prajapati K, Shah MC, Parmar N. Analysing barriers in acceptance of postpartum intrauterine device (PPIUCD) at tertiary care hospital of Gujarat. NJIRM. 2017;8(5):9-12.

Garuda L, Kambham S, Ohita B. Clinical outcome of PPIUCD (Copper-380A) intra-caesarean insertion. Indian J Obstetr Gynaecol Res. 2015;2(4):218-26.

Singal S, Bharti R, Dewan R, Divya, Dabral A, Batra A, et al. Clinical outcome of postplacental copper T 380A insertion in women delivering by caesarean section. J Clin Diagn Res. 2014;8(9):OC01-04.

Bedi PK, Guliani MS, Bala S. A prospective study to assess the safety and expulsion rate of copper T 380A in immediate post-partum period during caesarean section. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):3195-9.

Arshad F, Ejaz L, Noreen H, Bano N, Syed S, Chaudhri R. Trans-caesarean insertion of intrauterine contraceptive device. JSOGP. 2014;4(2):73-8.

Mishra N, Dalal N, Joshi V. Intrauterine device insertion during caesarean section - a boon for rural women. IOSR-JDMS. 2013;8(3):21-3.

Sharma A, Gupta V, Bansal N, Sharma U, Tandon A. A prospective study of immediate postpartum intra uterine device insertion in a tertiary level hospital. IJRMS. 2015;3(1):183-7.

Rahman LM, Banerjee A. A study on IUCD insertion during postpartum period (PPIUCD). J Evid Based Med. 2016;3(69):3768-70.

VidyaRama R, Nagamani T, Prasad U. PPIUCD as a Long acting reversible contraceptive (LARC): an experience at a tertiary care centre. Int J Sci Res. 2015;4(5):3-5.

Zulficar BS, Javed BI, Khadeja B. Insertion of intrauterine contraceptive device at caesarean section. J Colg Phys Surg Pakistan. 2011;21(9):527-30.

Shanavas A, Jacob S, Chellamma N. Outcome of immediate postpartum intrauterine contraceptive device in caesarean versus vaginal insertion: a comparative study. Int J Reprod Contracept Obstet Gynecol. 2017;6(2):694-9.

Nayak AK, Jain MK. Experience on awareness, acceptability, safety, efficacy, complications and expulsion of post-partum intrauterine contraceptive device insertion. IJSS. 2017;5(I):207-12.

Halder A, Sowmya MS, Gayen A, Bhattacharya P, Mukherjee S, Datta S. A prospective study to evaluate vaginal insertion and intra-caesarean insertion of post-partum intrauterine contraceptive device. Indian J Obstetr Gynaecol Res. 2016;66(1):35-41.

Gupta A, Verma AR, Chauhan J. Evaluation of PPIUCD versus interval IUCD (380A) insertion in a teaching hospital of Western U. P. Int J Reprod Contracept Obstet Gynecol. 2013;2(2):204-8.

Celen S, Sucak A, Yildiz Y, Danışman N. Immediate postplacental insertion of an intrauterine contraceptive device during caesarean section. Contracept. 2011;84(3):240-3.

Gaikwad S, Gurram A. Immediate postpartum insertion of an intrauterine contraceptive device during caesarean section. IJBMR. 2014;4(2):195-7.

Mülller ALL, Ramos JGL, Martins-Costa SH. Transvaginal ultrasonographic assessment of the expulsion rate of intrauterine devices inserted in the immediate postpartum period: a pilot study. Contracept. 2005;72:192-5.

Downloads

Published

2020-07-23

Issue

Section

Original Research Articles